SAGE launches further two Therapeutic Advances journals


SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles:Therapeutic Advances in Chronic Diseaseand Therapeutic Advances in Endocrinology and Metabolism.

Therapeutic Advances in Chronic Diseasecovers the drug treatment of all major chronic diseases excluding cancer , publishing guidance on which drugs to use and when (i.e. expert opinion reviews, narrative reviews, analysis of published guidelines (editorials or reviews). Single-drug reviews (including brief reviews of new drugs) and drug class reviews are also published with the aim of providing practically relevant information to the doctor group that treats such patients. Editor-in-Chief of the journal, Michael Schachter, is Senior Lecturer of the National Heart and Lung Institute at Imperial College, London.

Therapeutic Advances in Endocrinology and Metabolic Disorders publishes the highest quality peer-reviewed original research, reviews, and scholarly comment on pioneering efforts and innovative studies in Endocrinology and Metabolism. Aimed at clinicians and researchers from the field it will be a forum for all views and reviews relating to this diverse discipline. The Editor in Chief is Glenn Matfin, specialist in Adult Diabetes and Endocrinology at the Joslin Diabetes Center, USA; the world’s preeminent diabetesresearch and clinical care organization.

Both international in scope, the journals follow the highly successful format of the existing seven Therapeutic Advances titles, offering rapid peer review and publication, with manuscripts published online within seven weeks of acceptance. Each journal publishes six issues per year and will be freely available on the award-winning SAGE Journals Online platform for the first three years of publication.

"The Therapeutic Advances series is a comprehensive and essential addition to medical publishing," said Tessa Picknett, Associate Director and Publisher, STM journals. "Our primary focus is to rapidly publish clinically-relevant, peer-reviewed original research and reviews, written by highly respected authors for busy specialists and other health professionals."